- Home
- ATNM vs BEST Comparison
ATNM vs BEST Comparison
Compare ATNM & BEST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- BEST
- Stock Information
- Founded
- ATNM 2000
- BEST 2007
- Country
- ATNM United States
- BEST China
- Employees
- ATNM N/A
- BEST N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- BEST
- Sector
- ATNM Health Care
- BEST
- Exchange
- ATNM Nasdaq
- BEST Nasdaq
- Market Cap
- ATNM 56.5M
- BEST 54.0M
- IPO Year
- ATNM N/A
- BEST N/A
- Fundamental
- Price
- ATNM $1.51
- BEST $2.69
- Analyst Decision
- ATNM Strong Buy
- BEST
- Analyst Count
- ATNM 5
- BEST 0
- Target Price
- ATNM $14.20
- BEST N/A
- AVG Volume (30 Days)
- ATNM 245.6K
- BEST 11.4K
- Earning Date
- ATNM 11-26-2024
- BEST 11-29-2024
- Dividend Yield
- ATNM N/A
- BEST N/A
- EPS Growth
- ATNM N/A
- BEST N/A
- EPS
- ATNM N/A
- BEST N/A
- Revenue
- ATNM $81,000.00
- BEST $1,183,106,017.00
- Revenue This Year
- ATNM $186.10
- BEST N/A
- Revenue Next Year
- ATNM $19,248.94
- BEST N/A
- P/E Ratio
- ATNM N/A
- BEST N/A
- Revenue Growth
- ATNM 80.00
- BEST 11.57
- 52 Week Low
- ATNM $1.33
- BEST $1.85
- 52 Week High
- ATNM $10.24
- BEST $2.77
- Technical
- Relative Strength Index (RSI)
- ATNM 36.23
- BEST 39.37
- Support Level
- ATNM $1.82
- BEST $2.68
- Resistance Level
- ATNM $1.97
- BEST $2.69
- Average True Range (ATR)
- ATNM 0.12
- BEST 0.02
- MACD
- ATNM -0.02
- BEST -0.00
- Stochastic Oscillator
- ATNM 11.52
- BEST 12.19
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About BEST BEST Inc. each representing twenty (20)
BEST Inc is a supply chain company. It provides a New Retail platform that offers technology-enabled integrated solutions such as supply chain management, express delivery, freight, merchandise sourcing, cross-border supply chain, last-mile, financial and value-added services. The Group operates in the following operating segments, Supply chain management services, Freight, Global and Others. The Others category principally relates to cross-border logistic coordination services. The majority of revenue generated from Freight segment.